Denali Therapeutics Receives $217,000,000 New Funding Round

  • Feed Type
  • Date
    5/15/2015
  • Company Name
    Denali Therapeutics
  • Mailing Address
    Undisclosed San Francisco, CA 94107 USA
  • Company Description
    Denali is founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
  • Website
    http://www.denalitherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $217,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company will use the funds to discover and develop effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy